Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Infection01:20

Infection

11.6K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
11.6K
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

524
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
524
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

676
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
676
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

2.5K
The pathophysiology of pneumonia involves the following steps:
2.5K
Stages of Infection01:26

Stages of Infection

64.7K
Stages of infection describe what happens to a susceptible host once a pathogen invades the human body. The stages of infection are incubation, prodromal, illness, stage of decline, and convalescence. The incubation stage is the period from exposure to a pathogen until symptoms start. The infected person is unaware of impending illness as the pathogens grow and multiply within the body. The duration may vary depending on the type of infection. The incubation period of measles averages ten to...
64.7K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

2.6K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
2.6K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Correction: Plasma Aβ42/p-Tau217 ratio and p-Tau217 independently predict CSF-defined Alzheimer's disease pathology in a Brazilian admixed cohort.

Frontiers in aging neuroscience·2026
Same author

Regional, functional and transcriptomic decoding of multidimensional brain structure alterations in obsessive-compulsive disorder.

Nature communications·2026
Same author

Towards patient-centered healthcare: a scoping review of soft skills training in medical schools.

BMC medical education·2026
Same author

Global performance of predictive models for dengue severity, hospitalization and mortality: a systematic review and meta-analysis of 146 studies.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

Irisin promotes selective changes in hippocampal mitochondrial metabolism in mice.

Biochemistry and biophysics reports·2026
Same author

Plasma Aβ42/p-Tau217 ratio and p-Tau217 independently predict CSF-defined Alzheimer's disease pathology in a Brazilian admixed cohort.

Frontiers in aging neuroscience·2026
Same journal

Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Estimated labor market outcomes of people progressing from preclinical to early-stage Alzheimer's disease in the United States.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Amyloid exacerbates tau and alpha-synuclein pathologies, behavioral impairments, and neuroinflammation in a mixed dementia model.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Ver todos los artículos relacionados
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: Jan 7, 2026

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses
09:07

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses

Published on: June 14, 2020

11.5K

Ciencia básica y patogénesis

Fernanda G Q Barros-Aragão1, Luis E Santos1, Talita Pinto2

  • 1D'Or Institute for Research and Education, Rio de Janeiro, RJ, Brazil.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
Resumen
Este resumen es generado por máquina.

Los pacientes neurológicos con COVID-19 muestran una proteína Tau elevada, similar a los pacientes con enfermedad de Alzheimer (EA), relacionada con la inflamación. La inflamación persistente y los problemas cognitivos posteriores al COVID-19 pueden aumentar el riesgo futuro de EA.

Palabras clave:
proteína Taubiomarcadoresinflamaciónenfermedad de AlzheimerCOVID-19síntomas neurológicosriesgo futuromarcadores inflamatoriosdéficits cognitivossupervivientes de COVID-19

Más Videos Relacionados

A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia
13:45

A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia

Published on: September 21, 2019

6.0K
Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses
08:38

Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses

Published on: February 22, 2019

6.3K

Videos de Experimentos Relacionados

Last Updated: Jan 7, 2026

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses
09:07

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses

Published on: June 14, 2020

11.5K
A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia
13:45

A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia

Published on: September 21, 2019

6.0K
Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses
08:38

Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses

Published on: February 22, 2019

6.3K

Área de la Ciencia:

  • Neurociencia; Inmunología; Enfermedades Infecciosas

Sus antecedentes:

  • El COVID-19 puede causar síntomas neurológicos y deterioro cognitivo, y la enfermedad de Alzheimer (EA) aumenta la gravedad del COVID-19.; La inflamación está implicada tanto en el COVID-19 como en la EA, lo que sugiere un posible vínculo molecular.; Aún no está claro si los pacientes con COVID-19 con problemas neurológicos presentan cambios moleculares relacionados con la EA.

Objetivo del estudio:

  • Investigar las alteraciones moleculares relacionadas con la patología de la enfermedad de Alzheimer (EA) en pacientes con COVID-19 con síntomas neurológicos.; Identificar posibles vínculos moleculares entre COVID-19 y EA para mejorar el seguimiento de los pacientes y las estrategias de prevención.

Principales métodos:

  • Análisis retrospectivo de biomarcadores en líquido cefalorraquídeo (LCR) (amiloide-beta, Tau) en controles, deterioro cognitivo leve, EA y pacientes con COVID-19 con síntomas neurológicos.; Correlación de biomarcadores del LCR con marcadores de inflamación (IL6, SII).; Evaluación prospectiva de biomarcadores en plasma (amiloide-beta, Tau) y resultados cognitivos en supervivientes de COVID-19 hasta un año después de la infección.

Principales resultados:

  • Los pacientes con COVID-19 con síntomas neurológicos mostraron niveles elevados de Tau en el LCR en el momento de la hospitalización, similar a los pacientes con EA.; No se detectaron cambios significativos en los niveles de amiloide-beta o pTau-181 en el LCR en pacientes con COVID-19.; Los biomarcadores del LCR y las citoquinas proinflamatorias se correlacionaron con la inflamación sistémica (SII).; La relación Tau/amiloide-beta en plasma aumentó en los supervivientes de COVID-19 con déficits cognitivos un año después de la infección.; Los cambios longitudinales de Tau en plasma se vieron influenciados por la gravedad de la enfermedad, la inflamación y los déficits cognitivos.

Conclusiones:

  • La inflamación es un factor clave en los cambios moleculares agudos y persistentes relacionados con la EA observados en pacientes con COVID-19.; Los supervivientes de COVID-19 con inflamación continua o síntomas cognitivos requieren una monitorización cuidadosa del posible riesgo futuro de EA.